Securities Litigation - Fideres

Fideres Contributes to ISS SCAS Publication on European Securities Litigation

Fideres is pleased to have contributed to the September 2025 ISS SCAS publication "Securities Litigation in EMEA Comes of Age"

Ottobre 8, 2025

Fideres Publishes Empirical Study on Goldman Decisions’ Impact on Securities Class Actions

Fideres has published new research in the Berkeley Business Law Journal analyzing how the Goldman decisions are reshaping price impact

Ottobre 1, 2025

Banks Push Risky TARF Products Despite History of Billion-Dollar Fines and Settlements

Key Points Target redemption forwards (“TARFs”) are complex foreign exchange products. TARFs attract investors with promises of “enhanced” exchange rates

Luglio 28, 2025

Fideres Comments On Treasury-Market Manipulation

Our Co-Head of Financial and Securities Litigation, Robert Chang, has been quoted in a Market Watch article on Treasury-Market manipulation.

Luglio 21, 2025

Fideres Hosts Seminar On The Current Framework For Securities Litigation In Germany

Yesterday, Fideres hosted a seminar on the current framework for securities litigation in Germany. The seminar covered the basis for

Giugno 18, 2025

Fideres Advises In Landmark First Group Shareholder Claim In The English Courts Against The Royal Bank Of Scotland

Fideres announces its advisory role to institutional investors represented by Stewarts in landmark Section 90 FSMA litigation against The Royal

Maggio 29, 2025

Fideres Announces The Appointment Of Connor Hurley As A Director

We’re excited to welcome Connor Hurley as a new Financial Economist and Director at Fideres. Connor holds a Master of Public

Aprile 22, 2025

Fideres Announces Affiliation Of Leading Financial Economist Dr. Matthew D. Cain

Fideres, a global economic consultancy renowned for supporting complex financial litigation for its law firm clients, is proud to announce

Fideres Advises In ImmunityBio Securities Expert Report

An expert report by Dr. Matthew D. Cain was filed supporting class certification in Chen v. ImmunityBio, Inc. (Case No.

Ottobre 22, 2024

Crypto ETFs: Simple Products, Big Market Risks

Key Points In January 2024, the SEC approved Bitcoin and Ethereum ETFs, opening the door to broader crypto investing with

Ottobre 17, 2024